Wednesday, July 2, 2014

Bone Marrow Transplantation - Table of Contents alert Volume 49 Issue 7

If you are unable to see the message below, click here to view.
Bone Marrow Transplantation

TABLE OF CONTENTS

Volume 49, Issue 7 (July 2014)

In this issue
Reviews
Special Report
Original Articles
Technical Report
Letters To The Editor
Corrigenda

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement

NEW DEALS: Lab equipment and services

Browse our library of savings and information!

Check Marketplace first 

VISIT MARKETPLACE TODAY 
 
 

Reviews

Top

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, G W Basak, A Bazarbachi, K Douglas, I Gabriel, L Garderet, C Geraldes, O Jaksic, M W Kattan, Z Koristek, F Lanza, R M Lemoli, L Mendeleeva, G Mikala, N Mikhailova, A Nagler, H C Schouten, D Selleslag, S Suciu, A Sureda, N Worel, P Wuchter, C Chabannon and R F Duarte

Bone Marrow Transplant 2014 49: 865-872; advance online publication, March 31, 2014; 10.1038/bmt.2014.39

Abstract | Full Text

Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers

Y-J Chang and X-J Huang

Bone Marrow Transplant 2014 49: 873-879; advance online publication, February 24, 2014; 10.1038/bmt.2014.19

Abstract | Full Text

Special Report

Top

Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee

R N Lown, J Philippe, W Navarro, S M van Walraven, L Philips-Johnson, M Fechter, R Pawson, M Bengtsson, M Beksac, S Field, H Yang and B E Shaw

Bone Marrow Transplant 2014 49: 880-886; advance online publication, April 7, 2014; 10.1038/bmt.2014.67

Abstract | Full Text

Original Articles

Top

ACUTE LEUKEMIA

Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

L Tucunduva, A Ruggeri, G Sanz, S Furst, G Socié, M Michallet, W Arcese, N Milpied, I Yakoub-Agha, W Linkesch, J Cornelissen, L Mannone, A P Iori, J-M Ribera, J Sanz, P Montesinos, D Purtill, M Labopin, E Gluckman, M Mohty and V Rocha

Bone Marrow Transplant 2014 49: 887-894; 10.1038/bmt.2014.72

Abstract | Full Text

Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation

J Tischer, N Engel, S Fritsch, D Prevalsek, M Hubmann, C Schulz, A K Zoellner, V Bücklein, S Lippl, R Reibke, C T Rieger, G Ledderose, H J Stemmler, W Hiddemann, C Schmid and A Hausmann

Bone Marrow Transplant 2014 49: 895-901; advance online publication, May 12, 2014; 10.1038/bmt.2014.83

Abstract | Full Text

LYMPHOMA

Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group

E Tse, T S Y Chan, L-P Koh, W-J Chng, W-S Kim, T Tang, S-T Lim, A K W Lie and Y-L Kwong

Bone Marrow Transplant 2014 49: 902-906; advance online publication, April 28, 2014; 10.1038/bmt.2014.65

Abstract | Full Text

PLASMA CELL DISORDERS

Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma

D M Greenfield, E Boland, Y Ezaydi, R J M Ross, S H Ahmedzai, J A Snowden and Late Effects Group

Bone Marrow Transplant 2014 49: 907-912; advance online publication, April 7, 2014; 10.1038/bmt.2014.63

Abstract | Full Text

INHERITED AND GENETIC DISORDERS

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease

M Bhatia, Z Jin, C Baker, M B Geyer, K Radhakrishnan, E Morris, P Satwani, D George, J Garvin, G Del Toro, W Zuckerman, M T Lee, M Licursi, R Hawks, E Smilow, L A Baxter-Lowe, J Schwartz and M S Cairo

Bone Marrow Transplant 2014 49: 913-920; advance online publication, May 5, 2014; 10.1038/bmt.2014.84

Abstract | Full Text

GRAFT SOURCE

Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion

M Yabe, T Morimoto, T Shimizu, T Koike, H Takakura, K Ohtsubo, A Fukumura, S Kato and H Yabe

Bone Marrow Transplant 2014 49: 921-926; advance online publication, April 28, 2014; 10.1038/bmt.2014.73

Abstract | Full Text

EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation

H-t Wang, Y-j Chang, L-p Xu, D-h Liu, Y Wang, K-y Liu and X-j Huang

Bone Marrow Transplant 2014 49: 927-933; advance online publication, April 28, 2014; 10.1038/bmt.2014.80

Abstract | Full Text

CELLULAR THERAPY

Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation

R Geyeregger, C Freimüller, J Stemberger, G Fischer, V Witt and G Fritsch

Bone Marrow Transplant 2014 49: 934-941; advance online publication, April 28, 2014; 10.1038/bmt.2014.86

Abstract | Full Text

GRAFT MANIPULATION

Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts

K Mizrahi, S Ash, T Peled, I Yaniv, J Stein and N Askenasy

Bone Marrow Transplant 2014 49: 942-949; advance online publication, April 28, 2014; 10.1038/bmt.2014.79

Abstract | Full Text

SUPPORTIVE CARE

Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT

T Czerw, M Labopin, N-C Gorin, S Giebel, D Blaise, P-Y Dumas, R Foa, M Attal, N Schaap, M Michallet, C Bonmati, H Veelken and M Mohty

Bone Marrow Transplant 2014 49: 950-954; advance online publication, April 7, 2014; 10.1038/bmt.2014.64

Abstract | Full Text

CONDITIONING

A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies

M Gotoh, S Yoshizawa, S Katagiri, T Suguro, M Asano, T Kitahara, D Akahane, S Okabe, T Tauchi, Y Ito and K Ohyashiki

Bone Marrow Transplant 2014 49: 955-960; advance online publication, April 14, 2014; 10.1038/bmt.2014.66

Abstract | Full Text

TRANSPLANT TOXICITIES

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

S L Ehlers, C A Bronars, C A Patten, T Brockman, C Hughes, P A Decker, J R Cerhan, W Hogan, A Dispenzieri, S Ansell, J Ebbert and D Gastineau

Bone Marrow Transplant 2014 49: 961-965; advance online publication, April 14, 2014; 10.1038/bmt.2014.70

Abstract | Full Text

GRAFT-VERSUS-HOST DISEASE

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

C Castilla-Llorente, P J Martin, G B McDonald, B E Storer, F R Appelbaum, H J Deeg, M Mielcarek, H Shulman, R Storb and R A Nash

Bone Marrow Transplant 2014 49: 966-971; advance online publication, April 28, 2014; 10.1038/bmt.2014.69

Abstract | Full Text

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD

Q Ma, D Li, R Carreño, R Patenia, K Y Tsai, M Xydes-Smith, A M Alousi, R E Champlin, G E Sale and V Afshar-Kharghan

Bone Marrow Transplant 2014 49: 972-976; advance online publication, April 28, 2014; 10.1038/bmt.2014.75

Abstract | Full Text

Technical Report

Top

Estimation of size of cord blood inventory based on high-resolution typing of HLAs

E Y Song, J Y Huh, S Y Kim, T G Kim, S Oh, J H Yoon, E Y Roh, M H Park, M S Kang and S Shin

Bone Marrow Transplant 2014 49: 977-979; advance online publication, April 28, 2014; 10.1038/bmt.2014.76

Abstract | Full Text

Letters To The Editor

Top

Feasibility of umbilical cord blood transplantation with a myeloablative, reduced toxicity-conditioning regimen

M Nishimoto, H Nakamae, M Nakamae, A Hirose, K Hagihara, H Koh, T Nakane, Y Terada and M Hino

Bone Marrow Transplant 2014 49: 980-981; advance online publication, April 7, 2014; 10.1038/bmt.2014.60

Full Text

Systemic lupus erythematosus complicated with thymoma and pure red cell aplasia (PCRA). CR of both complications following thymectomy and allogeneic haematopoietic SCT (HSCT), but persistence of antinuclear antibodies (ANA)

A M Marmont, A Bacigalupo, F Gualandi, S Bregante, M T van Lint and S Geroldi

Bone Marrow Transplant 2014 49: 982-983; advance online publication, May 12, 2014; 10.1038/bmt.2014.68

Full Text

Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation

Y-S Chen, X-J Kong, X-H Zhang and X-L Yin

Bone Marrow Transplant 2014 49: 984-985; advance online publication, April 14, 2014; 10.1038/bmt.2014.74

Full Text

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD

R T Kamble, A Scholoff, A G Obi, H E Heslop, M K Brenner and G Carrum

Bone Marrow Transplant 2014 49: 986-987; advance online publication, April 28, 2014; 10.1038/bmt.2014.77

Full Text

Isolated orbital relapse of multiple myeloma in a patient with severe chronic GVHD after allogeneic hematopoietic SCT

C Blecha, D Wolff, O Kölbl, E Huber, H Helbig, B Holler, E Holler and T Dietrich-Ntoukas

Bone Marrow Transplant 2014 49: 988-989; advance online publication, April 28, 2014; 10.1038/bmt.2014.81

Full Text

The commitment and evaluation of the quality management plan by professionals from accredited stem cell transplant centers in Spain

M-J Jiménez, C Ferra, O García, F de Arriba, S Jiménez, A Insunza, M Calabuig, A Mantecon, J Sánchez, M Torres, P Balsalobre, J Linio, A Jiménez, E Feliu and J-M Ribera

Bone Marrow Transplant 2014 49: 990-992; advance online publication, April 28, 2014; 10.1038/bmt.2014.85

Full Text

Peanut allergy transferred by BMT

W Ip, C Cale, P Veys and W Qasim

Bone Marrow Transplant 2014 49: 993-994; advance online publication, April 28, 2014; 10.1038/bmt.2014.95

Full Text

Corrigenda

Top

Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma

D M Greenfield, E Boland, Y Ezaydi, R J M Ross, S H Ahmedzai and J A Snowden on behalf of the Late Effects Group

Bone Marrow Transplant 2014 49: 995; advance online publication, May 19, 2014; 10.1038/bmt.2014.103

Full Text

Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT

S V Glavey, M A Gertz, A Dispenzieri, S Kumar, F Buadi, M Lacy, S R Hayman, P Kapoor, D Dingli, A McCurdy, W J Hogan, D A Gastineau and N Leung

Bone Marrow Transplant 2014 49: 996; 10.1038/bmt.2014.24

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: